long intergenic non-protein coding RNA 2659Genealiases: []
Q-omics provides the consensus-scored LINC02659 profile across patient tissues and cancer cell-line models. LINC02659 expression is associated with patient survival in 9 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC02659 is differentially expressed in 1, with the highest sampling consensus in KICH. Additionally, LINC02659 RNA expression shows 6,362 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight ACC, KICH, and STAD as cancer lineages where LINC02659 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02659 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02659 survival associations across molecular data types. LINC02659 RNA expression shows survival associations in the most cancer types (9). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02659 RNA expression–survival associations across cancer types. High LINC02659 expression shows unfavorable associations in ACC, COAD, HNSC, SKCM and THCA, but favorable associations in ESCA. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC02659 RNA expression.
This table summarizes LINC02659 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 1. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02659. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02659 shows lower tumor expression in KICH. The KICH box plot shows higher LINC02659 RNA expression in normal versus tumor tissue (log2 FC = −0.034, t-test p = .024).
This table shows molecular features associated with LINC02659 in patient tissues and cancer cell lines. In patient samples, LINC02659 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
